Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Feb. 24, 2022

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

Feb. 23, 2022

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Feb. 23, 2022

Code Bio and Takeda collaborate on gene therapies for rare diseases

Feb. 23, 2022

New DNA Damage Response Consortium seeks to advance brain cancer research

Feb. 23, 2022

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Feb. 22, 2022

BioNTech and Medigene collaborate to develop TCR-based immunotherapies for cancer

Feb. 22, 2022

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Feb. 22, 2022

Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo

Feb. 18, 2022

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...